相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia
Michel Cuenod et al.
MOLECULAR PSYCHIATRY (2022)
Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits
Lijuan Huo et al.
BMC PSYCHIATRY (2021)
Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
Evgeny A. Ermakov et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting
Ranjana Bhandari et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2021)
The mystery of claustral neural circuits and recent updates on its role in neurodegenerative pathology
Vladimir N. Nikolenko et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2021)
Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
Alex J. Murray et al.
FRONTIERS IN PSYCHIATRY (2021)
MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients
Daniella Dwir et al.
MOLECULAR PSYCHIATRY (2020)
The origin of NMDA receptor hypofunction in schizophrenia
Kazu Nakazawa et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia
Grant McQueen et al.
PSYCHOPHARMACOLOGY (2020)
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia
Caitlin O. B. Yolland et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Mitochondrial Dysfunction in Schizophrenia
Peiyan Ni et al.
BIOESSAYS (2020)
Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
David R. Goldsmith et al.
FRONTIERS IN PSYCHIATRY (2020)
Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials
Wen-Long Jiang et al.
TRANSLATIONAL PSYCHIATRY (2020)
Analysis of GWAS-Derived Schizophrenia Genes for Links to Ischemia-Hypoxia Response of the Brain
Rainald Schmidt-Kastner et al.
FRONTIERS IN PSYCHIATRY (2020)
Brain NMDA Receptors in Schizophrenia and Depression
Albert Adell
BIOMOLECULES (2020)
Salvianolic Acid B Improves Chronic Mild Stress-Induced Depressive Behaviors in Rats: Involvement of AMPK/SIRT1 Signaling Pathway
Dehua Liao et al.
JOURNAL OF INFLAMMATION RESEARCH (2020)
Transcriptional and imaging-genetic association of cortical interneurons, brain function, and schizophrenia risk
Kevin M. Anderson et al.
NATURE COMMUNICATIONS (2020)
The Role of Exosomes in Stemness and Neurodegenerative Diseases-Chemoresistant-Cancer Therapeutics and Phytochemicals
Narasimha M. Beeraka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?-Current Status
Kirill V. Bulygin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies-A Comprehensive Review
Gjumrakch Aliev et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
Heidi N. Boyda et al.
FRONTIERS IN PSYCHIATRY (2020)
Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
Sonja Orlovska-Waast et al.
MOLECULAR PSYCHIATRY (2019)
Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione
Tushar Kanti Das et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
Chanoch Miodownik et al.
CLINICAL NEUROPHARMACOLOGY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress
Li-Li Xu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Cell type-specific gene expression patterns associated with posttraumatic stress disorder in World Trade Center responders
Pei-Fen Kuan et al.
TRANSLATIONAL PSYCHIATRY (2019)
Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
Antonio Rampino et al.
FRONTIERS IN PSYCHIATRY (2019)
Biological control agent Rhizobium (=Agrobacterium) vitis strain ARK-1 suppresses expression of the essential and non-essential vir genes of tumorigenic R-vitis
Akira Kawaguchi et al.
BMC RESEARCH NOTES (2019)
Oxidative stress in drug-na⟨ve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders
Wolfgang Jordan et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2018)
Keap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress
Ji-chun Zhang et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2018)
The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress
P. Steullet et al.
MOLECULAR PSYCHIATRY (2018)
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
Philippe Conus et al.
SCHIZOPHRENIA BULLETIN (2018)
N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials
W. Zheng et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Neurobiology and consequences of social isolation stress in animal model-A comprehensive review
Faiza Mumtaz et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
A lack of GluN2A-containing NMDA receptors confers a vulnerability to redox dysregulation: Consequences on parvalbumin interneurons, and their perineuronal nets
Romain Cardis et al.
NEUROBIOLOGY OF DISEASE (2018)
Thiol/Disulfide Homeostasis in Schizophrenic Patients
Burak Kulaksizoglu et al.
NEUROCHEMICAL JOURNAL (2018)
Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies
Asli Ercan Dogan et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences
Luis Rafael Leite Sampaio et al.
NEUROSCIENCE (2018)
Thiol/disulphide homeostasis in schizophrenia patients with positive symptoms
Kubranur Unal et al.
NORDIC JOURNAL OF PSYCHIATRY (2018)
The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
Gislaine Z. Reus et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial
Zahra Sepehrmanesh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Mitochondrial function in individuals at clinical high risk for psychosis
Tania Da Silva et al.
SCIENTIFIC REPORTS (2018)
Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia
Leticia Gonzalez-Blanco et al.
REVISTA DE PSIQUIATRIA Y SALUD MENTAL (2018)
Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia
Tohru Ohnuma et al.
FRONTIERS IN PSYCHIATRY (2018)
Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression
Yanling Zhou et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis
Juan A. Gallego et al.
SCHIZOPHRENIA RESEARCH (2018)
Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders
Alan Breier et al.
SCHIZOPHRENIA RESEARCH (2018)
Multi-Target Approach for Drug Discovery against Schizophrenia
Magda Kondej et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia
Zhi-Le Bai et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2018)
N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial
Paul Klauser et al.
TRANSLATIONAL PSYCHIATRY (2018)
Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients
Huimei An et al.
TRANSLATIONAL PSYCHIATRY (2018)
Anticholinergic medication for antipsychotic-induced tardive dyskinesia
Hanna Bergman et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia
Mohammed Garba Magaji et al.
METABOLIC BRAIN DISEASE (2017)
Cognitive effects of adjunctive N-acetyl cysteine in psychosis
M. Rapado-Castro et al.
PSYCHOLOGICAL MEDICINE (2017)
Redox Dysregulation in Schizophrenia Revealed by in vivo NAD plus /NADH Measurement
Sang-Young Kim et al.
SCHIZOPHRENIA BULLETIN (2017)
Reductive Stress in Inflammation-Associated Diseases and the Pro-Oxidant Effect of Antioxidant Agents
Israel Perez-Torres et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
Henry Barron et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia
P. Steullet et al.
MOLECULAR PSYCHIATRY (2017)
High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia
Shohei Nishimon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Thiol/disulfide homeostasis in untreated schizophrenia patients
Canan Topcuoglu et al.
PSYCHIATRY RESEARCH (2017)
Glutamatergic metabolites among adolescents at risk for psychosis
Caroline Demro et al.
PSYCHIATRY RESEARCH (2017)
Oxidative and nitrosative stress biomarkers in chronic schizophrenia
Karine Maria Boll et al.
PSYCHIATRY RESEARCH (2017)
Age-related changes of superoxide dismutase activity in patients with schizophrenia
Vladimir V. Djordjevic et al.
VOJNOSANITETSKI PREGLED (2017)
SIRT1 Regulates Cognitive Performance and Ability of Learning and Memory in Diabetic and Nondiabetic Models
Yue Cao et al.
JOURNAL OF DIABETES RESEARCH (2017)
Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia
D. A. Maas et al.
TRANSLATIONAL PSYCHIATRY (2017)
High Resolution Spatial Mapping of Human Footprint across Antarctica and Its Implications for the Strategic Conservation of Avifauna
Luis R. Pertierra et al.
PLOS ONE (2017)
Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine Treatment
Aarron Phensy et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2017)
Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role of oxidative stress, nitric oxide and glutamate NMDA receptors
Andreia S. Cunha et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Weaving a Net of Neurobiological Mechanisms in Schizophrenia and Unraveling the Underlying Pathophysiology
Byron K. Y. Bitanihirwe et al.
BIOLOGICAL PSYCHIATRY (2016)
Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia
Monika P. Jadi et al.
BIOLOGICAL PSYCHIATRY (2016)
The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia
Kayla A. Chase et al.
BMC PSYCHIATRY (2016)
Microglial activation and progressive brain changes in schizophrenia
L. E. Laskaris et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Biomarkers for drug development in early psychosis: Current issues and promising directions
Donald C. Goff et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Linking early-life NMDAR hypofunction and oxidative stress inyschizophrenia pathogenesis
Giles E. Hardingham et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Oxidative Stress and DNA Damage in Untreated First-Episode Psychosis in Adolescents
Şeref Şimşek et al.
NEUROPSYCHOBIOLOGY (2016)
Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol
Marija Boskovic et al.
NUTRITIONAL NEUROSCIENCE (2016)
Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
Kart Kriisa et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A central hub in schizophrenia pathophysiology?
P. Steullet et al.
SCHIZOPHRENIA RESEARCH (2016)
Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors
Karine Zortea et al.
NUTRIENTS (2016)
Combination Therapy of Salvianolic Acid and Fluoxetine Improves the Cognitive Function of Rats with Chronic Stress-induced Depression
Lulu Yu et al.
WORLD NEUROSURGERY (2016)
Pyramidal Cell Selective Ablation of N-Methyl-D-Aspartate Receptor 1 Causes Increase in Cellular and Network Excitability
Valerie M. Tatard-Leitman et al.
BIOLOGICAL PSYCHIATRY (2015)
The NFKB1 polymorphism (rs4648068) is associated with the cell proliferation and motility in gastric cancer
Ying Chen et al.
BMC GASTROENTEROLOGY (2015)
Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods
Tomasz Pawelczyk et al.
BMC PSYCHIATRY (2015)
Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model
Hendrik Wesseling et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Oxidative stress in drug naive first episode psychosis and antioxidant effects of risperidone
Cristiano Noto et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications
Ashwini Rajasekaran et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism
Irena Smaga et al.
PHARMACOLOGICAL REPORTS (2015)
Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patients
U. Sertan Copoglu et al.
PSYCHIATRY RESEARCH (2015)
High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
Cristiano Noto et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2015)
Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
Paul S. Baxter et al.
NATURE COMMUNICATIONS (2015)
An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
Akihiro Shiina et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2015)
Premyelinated central axons express neurotoxic NMDA receptors: relevance to early developing white-matter injury
Tahani Huria et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood
Yumi Shirai et al.
PLOS ONE (2015)
Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries
Justin Davis et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process
M. Bonora et al.
CELL DEATH AND DIFFERENTIATION (2014)
Untangling GABAergic wiring in the cortical microcircuit
Yoshiyuki Kubota
CURRENT OPINION IN NEUROBIOLOGY (2014)
Targeting of NMDA receptors in new treatments for schizophrenia
Kenji Hashimoto
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
AMPK activation prevents prenatal stress-induced cognitive impairment: Modulation of mitochondrial content and oxidative stress
Ke Cao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Oligodendrocyte Precursor Cell-Intrinsic Effect of Rheb1 Controls Differentiation and Mediates mTORC1-Dependent Myelination in Brain
Yi Zou et al.
JOURNAL OF NEUROSCIENCE (2014)
GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells
Mei-Ling Liu et al.
MOLECULAR BIOSYSTEMS (2014)
DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan
D. J. Porteous et al.
MOLECULAR PSYCHIATRY (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
Inflammation and the two-hit hypothesis of schizophrenia
Keith A. Feigenson et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Is there an association between peripheral immune markers and structural/functional neuroimaging findings?
Thomas Frodl et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?
Benjamin Rolland et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine
Jan-Harry Cabungcal et al.
BIOLOGICAL PSYCHIATRY (2013)
Meta-Analysis of Oxidative Stress in Schizophrenia
Joshua Flatow et al.
BIOLOGICAL PSYCHIATRY (2013)
Prenatal stress increases the expression of proinflammatory cytokines and exacerbates the inflammatory response to LPS in the hippocampal formation of adult male mice
Yolanda Diz-Chaves et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
Mehdi Farokhnia et al.
CLINICAL NEUROPHARMACOLOGY (2013)
Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia
Cristiano Noto et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Questions about DISC1 as a genetic risk factor for schizophrenia
P. F. Sullivan
MOLECULAR PSYCHIATRY (2013)
Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia
Melis Inan et al.
NEUROBIOLOGY OF DISEASE (2013)
Glutamatergic Dysbalance and Oxidative Stress in In Vivo and In Vitro Models of Psychosis Based on Chronic NMDA Receptor Antagonism
Just Genius et al.
PLOS ONE (2013)
Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice
Yue Hou et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Changes in oxidative stress markers in patients with schizophrenia: The effect of antipsychotic drugs
Meng-Chang Tsai et al.
PSYCHIATRY RESEARCH (2013)
Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia
Zhihong Jiang et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2013)
When Physicians Counsel About Stress: Results of a National Study
Aditi Nerurkar et al.
JAMA INTERNAL MEDICINE (2013)
Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder
Anita Kulak et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Genome-wide association studies of schizophrenia: does bigger lead to better results?
Sarah E. Bergen et al.
CURRENT OPINION IN PSYCHIATRY (2012)
A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia
Josue Perez-Santiago et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Molecular Links between Mitochondrial Dysfunctions and Schizophrenia
Cana Park et al.
MOLECULES AND CELLS (2012)
Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia
Susan B. Powell et al.
NEUROPHARMACOLOGY (2012)
Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia
Xiang Yang Zhang et al.
NEUROPHARMACOLOGY (2012)
Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain
Tihomir Stojkovic et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
NMDA Receptor and Schizophrenia: A Brief History
Joseph T. Coyle
SCHIZOPHRENIA BULLETIN (2012)
A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder
Mark Weiser et al.
SCHIZOPHRENIA RESEARCH (2012)
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
David A. Lewis et al.
TRENDS IN NEUROSCIENCES (2012)
The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics
Daniel Martins-de-Souza et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
Daisuke Matsuzawa et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Jeffrey K. Yao et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Mitochondrial DNA (mtDNA) and schizophrenia
B. Verge et al.
EUROPEAN PSYCHIATRY (2011)
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
Hayley B. Clay et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2011)
Oxidative stress in schizophrenia: An integrated approach
Byron K. Y. Bitanihirwe et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene
Bashayer Mubarak et al.
Channels (2010)
Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia
Vidhi Singh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses
Silvia Sorce et al.
JOURNAL OF NEUROSCIENCE (2010)
Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia
J. K. Yao et al.
MOLECULAR PSYCHIATRY (2010)
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
Juan E. Belforte et al.
NATURE NEUROSCIENCE (2010)
Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration
Nevena V. Radonjic et al.
NEUROPHARMACOLOGY (2010)
Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients
Cedo Mijevic et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
A meta-analysis of oxidative stress markers in schizophrenia
Zhang Ming et al.
SCIENCE CHINA-LIFE SCIENCES (2010)
The acute effects of NMDA antagonism: From the rodent to the human brain
Handan Gunduz-Bruce
BRAIN RESEARCH REVIEWS (2009)
Redox dysregulation, neurodevelopment, and schizophrenia
Kim Q. Do et al.
CURRENT OPINION IN NEUROBIOLOGY (2009)
Understanding the Role of DISC1 in Psychiatric Disease and during Normal Development
Nicholas J. Brandon et al.
JOURNAL OF NEUROSCIENCE (2009)
Classification of NPY-Expressing Neocortical Interneurons
Anastassios Karagiannis et al.
JOURNAL OF NEUROSCIENCE (2009)
Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia
Hitomi Ueno et al.
MITOCHONDRION (2009)
Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?
M. Margarita Behrens et al.
NEUROPHARMACOLOGY (2009)
Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
Brandi Rollins et al.
PLOS ONE (2009)
Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics
Xiang Yang Zhang et al.
PSYCHOPHARMACOLOGY (2009)
The Neurodevelopmental Hypothesis of Schizophrenia, Revisited
S. Hossein Fatemi et al.
SCHIZOPHRENIA BULLETIN (2009)
A double-blind trial of adjunctive allopurinol for schizophrenia
Faith B. Dickerson et al.
SCHIZOPHRENIA RESEARCH (2009)
Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1
Hanna Jaaro-Peled et al.
TRENDS IN NEUROSCIENCES (2009)
Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia
Mahmut Bulut et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
Mitochondrial involvement in psychiatric disorders
Ling Shao et al.
ANNALS OF MEDICINE (2008)
N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons
Pascal Steullet et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study
Afshar Amiri et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia
Ali Doruk et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia
M. Margarita Behrens et al.
JOURNAL OF NEUROSCIENCE (2008)
Mitochondria in Neuroplasticity and Neurological Disorders
Mark P. Mattson et al.
NEURON (2008)
Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study
Daisuke Matsuzawa et al.
PLOS ONE (2008)
Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major Depression
Dorit Ben-Shachar et al.
PLOS ONE (2008)
The case for autoimmunity in the etiology of schizophrenia
Carroll-Ann W. Goldsmith et al.
PHARMACOTHERAPY (2008)
The role of pro-inflammatory factors in mediating the effects on the fetus of prenatal undernutrition: Implications for schizophrenia
Q. Shen et al.
SCHIZOPHRENIA RESEARCH (2008)
The Role of NF-kappa B in PPAR alpha-Mediated Hepatocarcinogenesis
Howard P. Glauert et al.
PPAR RESEARCH (2008)
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients
Suzie Lavoie et al.
NEUROPSYCHOPHARMACOLOGY (2008)
The DISC locus in psychiatric illness
J. E. Chubb et al.
MOLECULAR PSYCHIATRY (2008)
Impaired glutathione synthesis in schizophrenia:: Convergent genetic and functional evidence
Rene Gysin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The impact of ω-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol:: An open-label pilot study
E. Y. Sivrioglu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment
Ash Sarandol et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Mitochondrial DNA HV lineage increases the susceptibility to schizophrenia among Israeli Arabs
Shirly Amar et al.
SCHIZOPHRENIA RESEARCH (2007)
Oxidative stress and aberrant signaling in aging and cognitive decline
Wulf Droge et al.
AGING CELL (2007)
Chinese herbal medicine for schizophrenia - Cochrane systematic review of randomised trials
John Rathbone et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
Charles H. Large
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis
Dai-Ying Zuo et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Alterations in peripheral blood lymphocyte cytokine expression in obesity
R. W. O'Rourke et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics
An-a Kazuno et al.
PLOS GENETICS (2006)
Mitochondria: Dynamic organelles in disease, aging, and development
David C. Chan
CELL (2006)
New variants in the mitochondrial genomes of schizophrenic patients
L Martorell et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
The effects of eicosapentaenoic acid in tardive dyskinesia: A randomized, placebo-controlled trial
Robin Emsley et al.
SCHIZOPHRENIA RESEARCH (2006)
Altered glutathione redox state in schizophrenia
Jeffrey K. Yao et al.
DISEASE MARKERS (2006)
Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia
GN Dakhale et al.
PSYCHOPHARMACOLOGY (2005)
A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder
NA Sachs et al.
MOLECULAR PSYCHIATRY (2005)
Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts
CA Altar et al.
BIOLOGICAL PSYCHIATRY (2005)
Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia
K Munakata et al.
BIOLOGICAL PSYCHIATRY (2005)
A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia
MG Brunstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia
JA Bodkin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial
S Akhondzadeh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis
K Iwamoto et al.
HUMAN MOLECULAR GENETICS (2005)
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
PJ Harrison et al.
MOLECULAR PSYCHIATRY (2005)
Mitochondrial complex I subunits expression is altered in schizophrenia: A postmortem study
R Karry et al.
BIOLOGICAL PSYCHIATRY (2004)
The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: A double-blind placebo-controlled trial
XY Zhang et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress
S Prabakaran et al.
MOLECULAR PSYCHIATRY (2004)
Increased nitric oxide radicals in postmortem brain from patients with schizophrenia
JK Yao et al.
SCHIZOPHRENIA BULLETIN (2004)
Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype
DL Garver et al.
NEUROPSYCHOPHARMACOLOGY (2003)
A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress
RM Marchbanks et al.
SCHIZOPHRENIA RESEARCH (2003)
Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain
V Parikh et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2003)
Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia
R Emsley et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Schizophrenia: Diverse approaches to a complex disease
A Sawa et al.
SCIENCE (2002)
Severe tardive dyskinesia in affective disorders: Treatment with vitamin E and C
Nikolaus Michael et al.
NEUROPSYCHOBIOLOGY (2002)
Substance P and nitric oxide signaling in cerebral cortex: Anatomical evidence for reciprocal signaling between two classes of interneurons
M Vruwink et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2001)
A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia
WS Fenton et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Effects of ketamine in normal and schizophrenic volunteers
AC Lahti et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia
M Peet et al.
SCHIZOPHRENIA RESEARCH (2001)
Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia
JK Millar et al.
MOLECULAR PSYCHIATRY (2001)
Oxidative damage and schizophrenia - An overview of the evidence and its therapeutic implications
JK Yao et al.
CNS DRUGS (2001)
Catching up on schizophrenia: Natural history and neurobiology
DA Lewis et al.
NEURON (2000)
分享论文
